Hepatitis B surface antigen-positive organ transplantation recipients: can lamivudine alter their fate?
Leung
N
N
D002353:Carrier State / Q000188:drug therapy* / Q000276:immunology; D018450:Disease Progression; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008111:Liver Function Tests; D016377:Organ Transplantation; D011183:Postoperative Complications / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D015996:Survival Rate; D014181:Transplantation Immunology; D016896:Treatment Outcome; D014775:Virus Activation / Q000187:drug effects* / Q000276:immunology
D006514:Hepatitis B Surface Antigens; D019259:Lamivudine